J R Downing - Concepedia

Author

J R Downing

St. Jude Children's Research Hospital

Also Known As

J Downing, J R Downing, James R. Downing, James R. Downing

Publications

Citations

H-Index

Concepts

All Affiliations

St. Jude Children's Research Hospital University of Tennessee Health Science Center The University of Texas MD Anderson Cancer Center

About

J R Downing is an author at St. Jude Children's Research Hospital specializing in medicine, cell biology, and cell signaling.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	922
2	Cell Biology	3	3	765
3	Immunology	2	2	725
4	Cellular Physiology	1	1	26
5	Pathology	1	1	95

J R Downing

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Genetic Alterations Activating Kinase and Cytokine Receptor Signaling in High-Risk Acute Lymphoblastic Leukemia Kathryn G. Roberts, Ryan D. Morin, Jinghui Zhang, Cancer Cell Hematological MalignancyCell SignalingMalignant Blood DisorderMixed-phenotype Acute LeukemiaImmunology	2012	699
TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Sheila Shurtleff, Arjan Buijs, F G Behm, PubMed	1995	561
Rationale and design of Total Therapy Study XV for newly diagnosed childhood acute lymphoblastic leukemia. Ching‐Hon Pui, M V Relling, J T Sandlund, PubMed	2004	366
11q23/MLL rearrangement confers a poor prognosis in infants with acute lymphoblastic leukemia. C-H Pui, F G Behm, J R Downing, Journal of Clinical Oncology	1994	208
11q23 rearrangements in acute leukemia. Jeffrey E. Rubnitz, Frederick G. Behm, J R Downing PubMed	1996	192
Reappraisal of the clinical and biologic significance of myeloid-associated antigen expression in childhood acute lymphoblastic leukemia. CH Pui, Jeffrey E. Rubnitz, M L Hancock, Journal of Clinical Oncology	1998	99
IDH1 and IDH2 mutations in pediatric acute leukemia Anna Andersson, D. W. Miller, Julie A. Lynch, Leukemia Hematological MalignancyMedicineGeneticsMixed-phenotype Acute LeukemiaHematology	2011	95
Acute Lymphoblastic Leukemia in a Developing Country: Preliminary Results of a Nonrandomized Clinical Trial in El Salvador Miguel Bonilla, Nelson Moreno, Neyssa Marina, The American journal of pediatric hematology/oncology	2000	95
Combination of cladribine and cytarabine is effective for childhood acute myeloid leukemia: results of the St Jude AML97 trial Jeffrey E. Rubnitz, Kristine R. Crews, Stanley Pounds, Leukemia Hematological MalignancyOncologyMixed-phenotype Acute LeukemiaHematologyPediatrics	2009	62
AMKL chimeric transcription factors are potent inducers of leukemia Julie Dang, Sam R. Nance, Jing Ma, Leukemia Hematological MalignancyPotent InducersMedicineCell BiologyCell Signaling	2017	40

Page 1